Skip to main content

Advertisement

SpringerLink
Log in

Neuroimmune Pharmacology of Neurodegenerative and Mental Diseases

  • INVITED REVIEW
  • Published:
Journal of Neuroimmune Pharmacology Aims and scope Submit manuscript

Abstract

Neuroimmune pharmacology is a newly emerging field that intersects with neuroscience, immunology, and pharmacology and that is seeking avenues for translational research and better understanding of disease mechanisms. It focuses on the immunity of the central nervous system (CNS) which is greatly influenced by endogenous effectors, such as cytokines and neurotransmitters, and by exogenous substances, including therapeutic compounds, infectious pathogens, and drugs of abuse. In this article, we attempt to raise awareness of the pivotal discovery of how those mediators affect the immunity of the CNS in both physiological conditions and processes of certain mental illnesses, including psychiatric disorders, neurodegenerative diseases, and cerebral dysfunctions due to drugs of abuse. The abnormality in cytokine networks, neurotransmitter homeostasis, and other immune responses may be involved in the neuropathology associated with those mental illnesses, and the therapeutic effects of the potential treatments can be attributed, at least partially, to their immunomodulatory activities. However, the resulting inflammatory cytokines from certain treatments frequently cause psychiatric complications. In addition, the poor neuropathological outcomes frequently found among drug abusers with HIV-1 infection appear to be related to the neurotoxic and immunomodulatory effects of the drugs used. Importantly, glial cells, especially microglia and astrocytes, are key players in the immunomodulatory activities in the CNS, and the functioning CNS is largely dependent upon the reciprocal interactions between neurons and glial cells. Therefore, glia–neuron interactions have become a critical issue for further understanding the disease mechanism. From this review, readers will gain insights into the new field of neuroimmune pharmacology, with a focus on the impacts of CNS immunity on the mental illnesses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aarum J, Sandberg K, Haeberlein SL, Persson MA (2003) Migration and differentiation of neural precursor cells can be directed by microglia. Proc Natl Acad Sci USA 100:15983–15988

    CAS  PubMed  Google Scholar 

  • Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383:787–793

    CAS  PubMed  Google Scholar 

  • Akhondzadeh S, Tabatabaee M, Amini H, Ahmadi Abhari SA, Abbasi SH, Behnam B (2007) Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial. Schizophr Res 90:179–185

    PubMed  Google Scholar 

  • Akhondzadeh S, Jafari S, Raisi F, Nasehi AA, Ghoreishi A, Salehi B, Mohebbi-Rasa S, Raznahan M, Kamalipour A (2009) Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress Anxiety 26:607–611

    CAS  PubMed  Google Scholar 

  • Akiyama K (1999) Serum levels of soluble IL-2 receptor alpha, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration. Schizophr Res 37:97–106

    CAS  PubMed  Google Scholar 

  • Aksenov MY, Aksenova MV, Nath A, Ray PD, Mactutus CF, Booze RM (2006) Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor. Neurotoxicology 27:217–228

    CAS  PubMed  Google Scholar 

  • Anthony IC, Bell JE (2008) The neuropathology of HIV/AIDS. Int Rev Psychiatry 20:15–24

    CAS  PubMed  Google Scholar 

  • Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789–1799

    CAS  PubMed  Google Scholar 

  • Aune TM, McGrath KM, Sarr T, Bombara MP, Kelley KA (1993) Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine. J Immunol 151:1175–1183

    CAS  PubMed  Google Scholar 

  • Bassil N, Grossberg GT (2009) Novel regimens and delivery systems in the pharmacological treatment of Alzheimer’s disease. CNS Drugs 23:293–307

    CAS  PubMed  Google Scholar 

  • Ben Achour S, Pascual O (2010) Glia: the many ways to modulate synaptic plasticity. Neurochem Int (in press)

  • Benbernou N, Esnault S, Shin HC, Fekkar H, Guenounou M (1997) Differential regulation of IFN-gamma, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway. Immunology 91:361–368

    CAS  PubMed  Google Scholar 

  • Berger JR, Avison M (2004) The blood brain barrier in HIV infection. Front Biosci 9:2680–2685

    CAS  PubMed  Google Scholar 

  • Berry CC, de la Fuente JM, Mullin M, Chu SW, Curtis AS (2007) Nuclear localization of HIV-1 tat functionalized gold nanoparticles. IEEE Trans Nanobioscience 6:262–269

    CAS  PubMed  Google Scholar 

  • Bilbo SD, Schwarz JM (2009) Early-life programming of later-life brain and behavior: a critical role for the immune system. Front Behav Neurosci 3:1–14

    Google Scholar 

  • Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57–69

    CAS  PubMed  Google Scholar 

  • Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA (1995) Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-d-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 92:7162–7166

    CAS  PubMed  Google Scholar 

  • Cabral GA (2006) Drugs of abuse, immune modulation, and AIDS. J Neuroimmune Pharmacol 1:280–295

    PubMed  Google Scholar 

  • Cabral GA, Staab A (2005) Effects on the immune system. Handb Exp Pharmacol 168:385–423

    CAS  PubMed  Google Scholar 

  • Calabrese JR, Skwerer RG, Barna B, Gulledge AD, Valenzuela R, Butkus A, Subichin S, Krupp NE (1986) Depression, immunocompetence, and prostaglandins of the E series. Psychiatry Res 17:41–47

    CAS  PubMed  Google Scholar 

  • Capuron L, Ravaud A, Dantzer R (2001a) Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients. Psychosom Med 63:376–386

    CAS  PubMed  Google Scholar 

  • Capuron L, Ravaud A, Gualde N, Bosmans E, Dantzer R, Maes M, Neveu PJ (2001b) Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology 26:797–808

    CAS  PubMed  Google Scholar 

  • Casassus P, Caillat-Vigneron N, Martin A, Simon J, Gallais V, Beaudry P, Eclache V, Laroche L, Lortholary P, Raphael M, Guillevin L, Lortholary O (2002) Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicentre phase II trial on 20 patients. Br J Haematol 119:1090–1097

    CAS  PubMed  Google Scholar 

  • Cazzullo CL, Sacchetti E, Galluzzo A, Panariello A, Adorni A, Pegoraro M, Bosis S, Colombo F, Trabattoni D, Zagliani A, Clerici M (2002) Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study. Prog Neuropsychopharmacol Biol Psychiatry 26:33–39

    CAS  PubMed  Google Scholar 

  • Chana G, Everall IP, Crews L, Langford D, Adame A, Grant I, Cherner M, Lazzaretto D, Heaton R, Ellis R, Masliah E (2006) Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users. Neurology 67:1486–1489

    CAS  PubMed  Google Scholar 

  • Collantes-Estevez E, Fernandez-Perez C (2003) Improved control of osteoarthritis pain and self-reported health status in non-responders to celecoxib switched to rofecoxib: results of PAVIA, an open-label post-marketing survey in Spain. Curr Med Res Opin 19:402–410

    CAS  PubMed  Google Scholar 

  • Cosenza MA, Zhao ML, Si Q, Lee SC (2002) Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis. Brain Pathol 12:442–455

    CAS  PubMed  Google Scholar 

  • Cysique LA, Brew BJ (2009) Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review. Neuropsychol Rev 19:169–185

    PubMed  Google Scholar 

  • Dhillon NK, Williams R, Callen S, Zien C, Narayan O, Buch S (2008) Roles of MCP-1 in development of HIV-dementia. Front Biosci 13:3913–3918

    CAS  PubMed  Google Scholar 

  • Donahoe RM, O’Neil SP, Marsteller FA, Novembre FJ, Anderson DC, Lankford-Turner P, McClure HH (2009) Probable deceleration of progression of Simian AIDS affected by opiate dependency: studies with a rhesus macaque/SIVsmm9 model. J Acquir Immune Defic Syndr 50:241–249

    PubMed  Google Scholar 

  • Dou H, Grotepas CB, McMillan JM, Destache CJ, Chaubal M, Werling J, Kipp J, Rabinow B, Gendelman HE (2009) Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS. J Immunol 183:661–669

    CAS  PubMed  Google Scholar 

  • Drzyzga L, Obuchowicz E, Marcinowska A, Herman ZS (2006) Cytokines in schizophrenia and the effects of antipsychotic drugs. Brain Behav Immun 20:532–545

    CAS  PubMed  Google Scholar 

  • Dunfee R, Thomas ER, Gorry PR, Wang J, Ancuta P, Gabuzda D (2006) Mechanisms of HIV-1 neurotropism. Curr HIV Res 4:267–278

    CAS  PubMed  Google Scholar 

  • Edgar VA, Sterin-Borda L, Cremaschi GA, Genaro AM (1999) Role of protein kinase C and cAMP in fluoxetine effects on human T-cell proliferation. Eur J Pharmacol 372:65–73

    CAS  PubMed  Google Scholar 

  • Eigler A, Siegmund B, Emmerich U, Baumann KH, Hartmann G, Endres S (1998) Anti-inflammatory activities of cAMP-elevating agents: enhancement of IL-10 synthesis and concurrent suppression of TNF production. J Leukoc Biol 63:101–107

    CAS  PubMed  Google Scholar 

  • Eilers M, Roy U, Mondal D (2008) MRP (ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and zidovudine, from human endothelial cells. Exp Biol Medicine (Maywood) 233:1149–1160

    CAS  Google Scholar 

  • Familian A, Eikelenboom P, Veerhuis R (2007) Minocycline does not affect amyloid beta phagocytosis by human microglial cells. Neurosci Lett 416:87–91

    CAS  PubMed  Google Scholar 

  • Fan R, Xu F, Previti ML, Davis J, Grande AM, Robinson JK, Van Nostrand WE (2007) Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid. J Neurosci 27:3057–3063

    CAS  PubMed  Google Scholar 

  • Feldman SR, Gottlieb AB, Bala M, Wu Y, Eisenberg D, Guzzo C, Li S, Dooley LT, Menter A (2008) Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis. Br J Dermatol 159:704–710

    CAS  PubMed  Google Scholar 

  • Ferjan I, Erjavec F (1996) Changes in histamine and serotonin secretion from rat peritoneal mast cells caused by antidepressants. Inflamm Res 45:141–144

    CAS  PubMed  Google Scholar 

  • Fetler L, Amigorena S (2005) Neuroscience. Brain under surveillance: the microglia patrol. Science 309:392–393

    CAS  PubMed  Google Scholar 

  • Finter NB (1996) The naming of cats—and alpha-interferons. Lancet 348:348–349

    CAS  PubMed  Google Scholar 

  • Friedman H, Newton C, Klein TW (2003) Microbial infections, immunomodulation, and drugs of abuse. Clin Microbiol Rev 16:209–219

    CAS  PubMed  Google Scholar 

  • Friedman H, Pross S, Klein TW (2006) Addictive drugs and their relationship with infectious diseases. FEMS Immunol Med Microbiol 47:330–342

    CAS  PubMed  Google Scholar 

  • Fukui S, Schwarcz R, Rapoport SI, Takada Y, Smith QR (1991) Blood–brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J Neurochem 56:2007–2017

    CAS  PubMed  Google Scholar 

  • Gao HM, Liu B, Zhang W, Hong JS (2003) Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson’s disease. FASEB J 17:1954–1956

    CAS  PubMed  Google Scholar 

  • Gaughran F (2002) Immunity and schizophrenia: autoimmunity, cytokines, and immune responses. Int Rev Neurobiol 52:275–302

    CAS  PubMed  Google Scholar 

  • Giri RK, Rajagopal V, Kalra VK (2004) Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor. J Neurochem 91:1199–1210

    CAS  PubMed  Google Scholar 

  • Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140:918–934

    CAS  PubMed  Google Scholar 

  • Golde TE (2006) Disease modifying therapy for AD? J Neurochem 99:689–707

    CAS  PubMed  Google Scholar 

  • Grant I (2008) Neurocognitive disturbances in HIV. Int Rev Psychiatry 20:33–47

    PubMed  Google Scholar 

  • Halassa MM, Haydon PG (2010) Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior. Annu Rev Physiol 72:335–355

    CAS  PubMed  Google Scholar 

  • Heneka MT, Sastre M, Dumitrescu-Ozimek L, Hanke A, Dewachter I, Kuiperi C, O’Banion K, Klockgether T, Van Leuven F, Landreth GE (2005) Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice. Brain 128:1442–1453

    PubMed  Google Scholar 

  • Hertz L (2006) Glutamate, a neurotransmitter—and so much more. A synopsis of Wierzba III. Neurochem Int 48:416–425

    CAS  PubMed  Google Scholar 

  • Hori T, Nakashima T, Take S, Kaizuka Y, Mori T, Katafuchi T (1991) Immune cytokines and regulation of body temperature, food intake and cellular immunity. Brain Res Bull 27:309–313

    CAS  PubMed  Google Scholar 

  • Huang JT, Welch JS, Ricote M, Binder CJ, Willson TM, Kelly C, Witztum JL, Funk CD, Conrad D, Glass CK (1999) Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 400:378–382

    CAS  PubMed  Google Scholar 

  • int' Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, Breteler MM, Stricker BH (2001) Nonsteroidal antiinflammatory drugs and the risk of Alzheimer’s disease. N Engl J Med 345:1515–1521

    Google Scholar 

  • Islam M, Frye RF, Richards TJ, Sbeitan I, Donnelly SS, Glue P, Agarwala SS, Kirkwood JM (2002) Differential effect of IFNalpha-2b on the cytochrome P450 enzyme system: a potential basis of IFN toxicity and its modulation by other drugs. Clin Cancer Res 8:2480–2487

    CAS  PubMed  Google Scholar 

  • Jantzen PT, Connor KE, DiCarlo G, Wenk GL, Wallace JL, Rojiani AM, Coppola D, Morgan D, Gordon MN (2002) Microglial activation and beta-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice. J Neurosci 22:2246–2254

    CAS  PubMed  Google Scholar 

  • Jiang J, Wang W, Sun YJ, Hu M, Li F, Zhu DY (2007) Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood–brain barrier damage. Eur J Pharmacol 561:54–62

    CAS  PubMed  Google Scholar 

  • Kang G, Kong PJ, Yuh YJ, Lim SY, Yim SV, Chun W, Kim SS (2004) Curcumin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor kappab bindings in BV2 microglial cells. J Pharmacol Sci 94:325–328

    CAS  PubMed  Google Scholar 

  • Kenis G, Maes M (2002) Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol 5:401–412

    CAS  PubMed  Google Scholar 

  • Khairova RA, Machado-Vieira R, Du J, Manji HK (2009) A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol 12:561–578

    CAS  PubMed  Google Scholar 

  • Kim YK, Kim L, Lee MS (2000) Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics. Schizophr Res 44:165–175

    CAS  PubMed  Google Scholar 

  • Kim DJ, Kim W, Yoon SJ, Go HJ, Choi BM, Jun TY, Kim YK (2001) Effect of risperidone on serum cytokines. Int J Neurosci 111:11–19

    CAS  PubMed  Google Scholar 

  • Kim SD, Yang SI, Kim HC, Shin CY, Ko KH (2007) Inhibition of GSK-3beta mediates expression of MMP-9 through ERK1/2 activation and translocation of NF-kappaB in rat primary astrocyte. Brain Res 1186:12–20

    CAS  PubMed  Google Scholar 

  • Kim J, Lee HJ, Lee KW (2010) Naturally occurring phytochemicals for the prevention of Alzheimer’s disease. J Neurochem 112:1415–1430

    CAS  PubMed  Google Scholar 

  • Kraft-Terry SD, Buch SJ, Fox HS, Gendelman HE (2009) A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection. Neuron 64:133–145

    CAS  PubMed  Google Scholar 

  • Krishnan R, Cella D, Leonardi C, Papp K, Gottlieb AB, Dunn M, Chiou CF, Patel V, Jahreis A (2007) Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks. Br J Dermatol 157:1275–1277

    CAS  PubMed  Google Scholar 

  • Kronfol Z, Remick DG (2000) Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 157:683–694

    CAS  PubMed  Google Scholar 

  • Kubera M, Kenis G, Bosmans E, Scharpe S, Maes M (2000) Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-gamma and interleukin-10. Neuropsychopharmacology 23:89–98

    CAS  PubMed  Google Scholar 

  • Kukar T, Murphy MP, Eriksen JL, Sagi SA, Weggen S, Smith TE, Ladd T, Khan MA, Kache R, Beard J, Dodson M, Merit S, Ozols VV, Anastasiadis PZ, Das P, Fauq A, Koo EH, Golde TE (2005) Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production. Nat Med 11:545–550

    CAS  PubMed  Google Scholar 

  • Kumar R, Orsoni S, Norman L, Verma AS, Tirado G, Giavedoni LD, Staprans S, Miller GM, Buch SJ, Kumar A (2006) Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques. Virology 354:192–206

    CAS  PubMed  Google Scholar 

  • Letendre SL, Woods SP, Ellis RJ, Atkinson JH, Masliah E, van den Brande G, Durelle J, Grant I, Everall I (2006) Lithium improves HIV-associated neurocognitive impairment. AIDS 20:1885–1888

    CAS  PubMed  Google Scholar 

  • Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Simpson D, Grant I, Ellis RJ (2008) Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65:65–70

    PubMed  Google Scholar 

  • Lim CS, Jin DQ, Mok H, Oh SJ, Lee JU, Hwang JK, Ha I, Han JS (2005) Antioxidant and antiinflammatory activities of xanthorrhizol in hippocampal neurons and primary cultured microglia. J Neurosci Res 82:831–838

    CAS  PubMed  Google Scholar 

  • Linnoila M, Whorton AR, Rubinow DR, Cowdry RW, Ninan PT, Waters RN (1983) CSF prostaglandin levels in depressed and schizophrenic patients. Arch Gen Psychiatry 40:405–406

    CAS  PubMed  Google Scholar 

  • Lipton SA (2004) Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer’s disease and other neurologic disorders. J Alzheimers Dis 6(Suppl):S61–S74

    CAS  PubMed  Google Scholar 

  • Loftis JM, Hauser P (2004) The phenomenology and treatment of interferon-induced depression. J Affect Disord 82:175–190

    CAS  PubMed  Google Scholar 

  • Lue LF, Rydel R, Brigham EF, Yang LB, Hampel H, Murphy GM Jr, Brachova L, Yan SD, Walker DG, Shen Y, Rogers J (2001) Inflammatory repertoire of Alzheimer’s disease and nondemented elderly microglia in vitro. Glia 35:72–79

    CAS  PubMed  Google Scholar 

  • Luna-Medina R, Cortes-Canteli M, Alonso M, Santos A, Martínez A, Perez-Castillo A (2005) Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation. J Biol Chem 280:21453–21462

    CAS  PubMed  Google Scholar 

  • Maes M (1995) Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 19:11–38

    CAS  PubMed  Google Scholar 

  • Maes M, Meltzer HY, Bosmans E (1994) Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine. Acta Psychiatr Scand 89:346–351

    CAS  PubMed  Google Scholar 

  • Maes M, Bosmans E, Kenis G, De Jong R, Smith RS, Meltzer HY (1997) In vivo immunomodulatory effects of clozapine in schizophrenia. Schizophr Res 26:221–225

    CAS  PubMed  Google Scholar 

  • Maes M, Bocchio Chiavetto L, Bignotti S, Battisa Tura GJ, Pioli R, Boin F, Kenis G, Bosmans E, de Jongh R, Altamura CA (2002) Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor. Schizophr Res 54:281–291

    PubMed  Google Scholar 

  • Malek-Ahmadi P (2001) Mood disorders associated with interferon treatment: theoretical and practical considerations. Ann Pharmacother 35:489–495

    CAS  PubMed  Google Scholar 

  • Martinez A, Alonso M, Castro A, Pérez C, Moreno FJ (2002) First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer’s disease. J Med Chem 45:1292–1299

    CAS  PubMed  Google Scholar 

  • Masek K, Slansky J, Petrovicky P, Hadden JW (2003) Neuroendocrine immune interactions in health and disease. Int Immunopharmacol 3:1235–1246

    CAS  PubMed  Google Scholar 

  • McArthur JC (1987) Neurologic manifestations of AIDS. Medicine (Baltimore) 66:407–437

    CAS  Google Scholar 

  • McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, Becker JT, Graham NM, McArthur JH, Selnes OA, Jacobson LP et al (1993) Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 43:2245–2252

    CAS  PubMed  Google Scholar 

  • McGeer PL, McGeer EG (1998) Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions. Alzheimer Dis Assoc Disord Suppl 2:S1–S6

    Google Scholar 

  • McGeer PL, McGeer EG (2007) NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies. Neurobiol Aging 28:639–647

    CAS  PubMed  Google Scholar 

  • McGeer PL, Schulzer M, McGeer EG (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer’s disease: a review of 17 epidemiologic studies. Neurology 47:425–432

    CAS  PubMed  Google Scholar 

  • Meisner F, Scheller C, Kneitz S, Sopper S, Neuen-Jacob E, Riederer P, ter Meulen V, Koutsilieri E (2008) Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine. Neuropsychopharmacology 33:2228–2236

    CAS  PubMed  Google Scholar 

  • Miller AH (2009) Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface. Brain Behav Immun 23:149–158

    CAS  PubMed  Google Scholar 

  • Miller DS, Bauer B, Hartz AM (2008) Modulation of P-glycoprotein at the blood–brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacol Rev 60:196–209

    CAS  PubMed  Google Scholar 

  • Mittleman BB, Castellanos FX, Jacobsen LK, Rapoport JL, Swedo SE, Shearer GM (1997) Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease. J Immunol 159:2994–2999

    CAS  PubMed  Google Scholar 

  • Miyamoto S, Duncan GE, Marx CE, Lieberman JA (2005) Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 10:79–104

    CAS  PubMed  Google Scholar 

  • Mogi M, Li JM, Tsukuda K, Iwanami J, Min LJ, Sakata A, Fujita T, Iwai M, Horiuchi M (2008) Telmisartan prevented cognitive decline partly due to PPAR-gamma activation. Biochem Biophys Res Commun 375:446–449

    CAS  PubMed  Google Scholar 

  • Monteleone P, Fabrazzo M, Tortorella A, Maj M (1997) Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment. Psychiatry Res 71:11–17

    CAS  PubMed  Google Scholar 

  • Moots RJ, Al-Saffar Z, Hutchinson D, Golding SP, Young SP, Bacon PA, McLaughlin PJ (1999) Old drug, new tricks: haloperidol inhibits secretion of proinflammatory cytokines. Ann Rheum Dis 58:585–587

    CAS  PubMed  Google Scholar 

  • Muller N, Riedel M, Gruber R, Ackenheil M, Schwarz MJ (2000) The immune system and schizophrenia. An integrative view. Ann NY Acad Sci 917:456–467

    CAS  PubMed  Google Scholar 

  • Muller N, Riedel M, Scheppach C, Brandstatter B, Sokullu S, Krampe K, Ulmschneider M, Engel RR, Moller HJ, Schwarz MJ (2002) Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am J Psychiatry 159:1029–1034

    PubMed  Google Scholar 

  • Muller N, Strassnig M, Schwarz MJ, Ulmschneider M, Riedel M (2004) COX-2 inhibitors as adjunctive therapy in schizophrenia. Expert Opin Investig Drugs 13:1033–1044

    PubMed  Google Scholar 

  • Muller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Muller B, Spellmann I, Hetzel G, Maino K, Kleindienst N, Moller HJ, Arolt V, Riedel M (2006) The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 11:680–684

    CAS  PubMed  Google Scholar 

  • Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM (1998) Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 93:229–240

    CAS  PubMed  Google Scholar 

  • Nair MP, Saiyed ZM, Nair N, Gandhi NH, Rodriguez JW, Boukli N, Provencio-Vasquez E, Malow RM, Miguez-Burbano MJ (2009) Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells. J Neuroimmune Pharmacol 4:129–139

    PubMed  Google Scholar 

  • Nath A, Haughey NJ, Jones M, Anderson C, Bell JE, Geiger JD (2000) Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann Neurol 47:186–194

    CAS  PubMed  Google Scholar 

  • Nath A, Schiess N, Venkatesan A, Rumbaugh J, Sacktor N, McArthur J (2008) Evolution of HIV dementia with HIV infection. Int Rev Psychiatry 20:25–31

    PubMed  Google Scholar 

  • Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314–1318

    CAS  PubMed  Google Scholar 

  • Norris JG, Benveniste EN (1993) Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine. J Neuroimmunol 45:137–145

    CAS  PubMed  Google Scholar 

  • Nowacek A, Gendelman HE (2009) NanoART, neuroAIDS and CNS drug delivery. Nanomedicine (Lond) 4:557–574

    CAS  Google Scholar 

  • O'Brien SM, Scott LV, Dinan TG (2004) Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum Psychopharmacol 19:397–403

    PubMed  Google Scholar 

  • O’Brien SM, Scully P, Dinan TG (2008) Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia. Psychiatry Res 160:256–262

    PubMed  Google Scholar 

  • Ohishi K, Ueno R, Nishino S, Sakai T, Hayaishi O (1988) Increased level of salivary prostaglandins in patients with major depression. Biol Psychiatry 23:326–334

    CAS  PubMed  Google Scholar 

  • Opp MR (2005) Cytokines and sleep. Sleep Med Rev 9:355–364

    PubMed  Google Scholar 

  • Pae CU, Yoon CH, Kim TS, Kim JJ, Park SH, Lee CU, Lee SJ, Lee C, Paik IH (2006) Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines. Int Immunopharmacol 6:666–671

    CAS  PubMed  Google Scholar 

  • Park S, Geddes TJ, Javitch JA, Kuhn DM (2003) Dopamine prevents nitration of tyrosine hydroxylase by peroxynitrite and nitrogen dioxide: is nitrotyrosine formation an early step in dopamine neuronal damage? J Biol Chem 278:28736–28742

    CAS  PubMed  Google Scholar 

  • Petrovsky N (2001) Towards a unified model of neuroendocrine–immune interaction. Immunol Cell Biol 79:350–357

    CAS  PubMed  Google Scholar 

  • Pollmacher T, Hinze-Selch D, Mullington J (1996) Effects of clozapine on plasma cytokine and soluble cytokine receptor levels. J Clin Psychopharmacol 16:403–409

    CAS  PubMed  Google Scholar 

  • Pollmacher T, Hinze-Selch D, Fenzel T, Kraus T, Schuld A, Mullington J (1997) Plasma levels of cytokines and soluble cytokine receptors during treatment with haloperidol. Am J Psychiatry 154:1763–1765

    CAS  PubMed  Google Scholar 

  • Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E (2008) Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 63:801–808

    CAS  PubMed  Google Scholar 

  • Rahman I, Marwick J, Kirkham P (2004) Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Biochem Pharmacol 68:1255–1267

    CAS  PubMed  Google Scholar 

  • Rainey-Smith SR, Andersson DA, Williams RJ, Rattray M (2010) Tumour necrosis factor alpha induces rapid reduction in AMPA receptor-mediated calcium entry in motor neurones by increasing cell surface expression of the GluR2 subunit: relevance to neurodegeneration. J Neurochem 113:692–703

    CAS  PubMed  Google Scholar 

  • Ramchand R, Wei J, Ramchand CN, Hemmings GP (1994) Increased serum IgE in schizophrenic patients who responded poorly to neuroleptic treatment. Life Sci 54:1579–1584

    CAS  PubMed  Google Scholar 

  • Randall RE, Goodbourn S (2008) Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89:1–47

    CAS  PubMed  Google Scholar 

  • Riedel M, Spellmann I, Schwarz MJ, Strassnig M, Sikorski C, Moller HJ, Muller N (2007) Decreased T cellular immune response in schizophrenic patients. J Psychiatr Res 41:3–7

    PubMed  Google Scholar 

  • Rippeth JD, Heaton RK, Carey CL, Marcotte TD, Moore DJ, Gonzalez R, Wolfson T, Grant I (2004) Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc 10:1–14

    CAS  PubMed  Google Scholar 

  • Rothermundt M, Arolt V, Bayer TA (2001) Review of immunological and immunopathological findings in schizophrenia. Brain Behav Immun 15:319–339

    CAS  PubMed  Google Scholar 

  • Roy S, Wang J, Kelschenbach J, Koodie L, Martin J (2006) Modulation of immune function by morphine: implications for susceptibility to infection. J Neuroimmune Pharmacol 1:77–89

    PubMed  Google Scholar 

  • Sacre S, Medghalchi M, Gregory B, Brennan F, Williams R (2010) Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit Toll-like receptors. Arthritis Rheum 62:683–693

    CAS  PubMed  Google Scholar 

  • Saper CB, Breder CD (1994) The neurologic basis of fever. N Engl J Med 330:1880–1886

    CAS  PubMed  Google Scholar 

  • Sawada M, Suzumura A, Marunouchi T (1995) Cytokine network in the central nervous system and its roles in growth and differentiation of glial and neuronal cells. Int J Dev Neurosci 13:253–264

    CAS  PubMed  Google Scholar 

  • Scher JU, Pillinger MH (2009) The anti-inflammatory effects of prostaglandins. J Investig Med 57:703–708

    CAS  PubMed  Google Scholar 

  • Schifitto G, Peterson DR, Zhong J, Ni H, Cruttenden K, Gaugh M, Gendelman HE, Boska M, Gelbard H (2006) Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report. Neurology 66:919–921

    CAS  PubMed  Google Scholar 

  • Schifitto G, Navia BA, Yiannoutsos CT, Marra CM, Chang L, Ernst T, Jarvik JG, Miller EN, Singer EJ, Ellis RJ, Kolson DL, Simpson D, Nath A, Berger J, Shriver SL, Millar LL, Colquhoun D, Lenkinski R, Gonzalez RG, Lipton SA (2007) Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. AIDS 21:1877–1886

    CAS  PubMed  Google Scholar 

  • Schousboe A (2003) Role of astrocytes in the maintenance and modulation of glutamatergic and GABAergic neurotransmission. Neurochem Res 28:347–352

    CAS  PubMed  Google Scholar 

  • Schousboe A, Sarup A, Bak LK, Waagepetersen HS, Larsson OM (2004) Role of astrocytic transport processes in glutamatergic and GABAergic neurotransmission. Neurochem Int 45:521–527

    CAS  PubMed  Google Scholar 

  • Schuld A, Kraus T, Haack M, Hinze-Selch D, Kuhn M, Pollmacher T (2000) Plasma levels of cytokines and soluble cytokine receptors during treatment with olanzapine. Schizophr Res 43:164–166

    CAS  PubMed  Google Scholar 

  • Schwarcz R, Whetsell WO Jr, Mangano RM (1983) Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219:316–318

    CAS  PubMed  Google Scholar 

  • Selkoe DJ (2001) Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev 81:741–766

    CAS  PubMed  Google Scholar 

  • Shen Y, Connor TJ, Nolan Y, Kelly JP, Leonard BE (1999) Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat. Life Sci 65:1773–1786

    CAS  PubMed  Google Scholar 

  • Shie FS, Woltjer RL (2007) Manipulation of microglial activation as a therapeutic strategy in Alzheimer’s disease. Curr Med Chem 14:2865–2871

    CAS  PubMed  Google Scholar 

  • Sleijfer S, Bannink M, Van Gool AR, Kruit WH, Stoter G (2005) Side effects of interferon-alpha therapy. Pharm World Sci 27:423–431

    CAS  PubMed  Google Scholar 

  • Song C, Lin A, Bonaccorso S, Heide C, Verkerk R, Kenis G, Bosmans E, Scharpe S, Whelan A, Cosyns P, de Jongh R, Maes M (1998) The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J Affect Disord 49:211–219

    CAS  PubMed  Google Scholar 

  • Speciale C, Hares K, Schwarcz R, Brookes N (1989) High-affinity uptake of l-kynurenine by a Na+-independent transporter of neutral amino acids in astrocytes. J Neurosci 9:2066–2072

    CAS  PubMed  Google Scholar 

  • Stolina M, Sharma S, Lin Y, Dohadwala M, Gardner B, Luo J, Zhu L, Kronenberg M, Miller PW, Portanova J, Lee JC, Dubinett SM (2000) Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J Immunol 164:361–370

    CAS  PubMed  Google Scholar 

  • Struzyńska LA (2009) Glutamatergic component of lead toxicity in adult brain: the role of astrocytic glutamate transporters. Neurochem Int 55:151–156

    PubMed  Google Scholar 

  • Szabo G (1997) Alcohol’s contribution to compromised immunity. Alcohol Health Res World 21:30–41

    CAS  PubMed  Google Scholar 

  • Szelenyi J (2001) Cytokines and the central nervous system. Brain Res Bull 54:329–338

    CAS  PubMed  Google Scholar 

  • Taler M, Gil-Ad I, Lomnitski L, Korov I, Baharav E, Bar M, Zolokov A, Weizman A (2007) Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression. Eur Neuropsychopharmacol 17:774–780

    CAS  PubMed  Google Scholar 

  • Taler M, Bar M, Korob I, Lomnitski L, Baharav E, Grunbaum-Novak N, Weizman A, Gil-Ad I (2008) Evidence for an inhibitory immunomodulatory effect of selected antidepressants on rat splenocytes: possible relevance to depression and hyperactive-immune disorders. Int Immunopharmacol 8:526–533

    CAS  PubMed  Google Scholar 

  • Taylor DL, Jones F, Kubota ES, Pocock JM (2005) Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand. J Neurosci 25:2952–2964

    CAS  PubMed  Google Scholar 

  • Thadani PV, Sharp C (1994) Drugs of abuse and dysfunction of neuroendocrine and immune systems: the importance of animal research. J Addict Dis 13:1–8

    CAS  PubMed  Google Scholar 

  • Turnbull AV, Rivier C (1995) Regulation of the HPA axis by cytokines. Brain Behav Immun 9:253–275

    CAS  PubMed  Google Scholar 

  • Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, Lalla D, Woolley M, Jahreis A, Zitnik R, Cella D, Krishnan R (2006) Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 367:29–35

    CAS  PubMed  Google Scholar 

  • Tzingounis AV, Wadiche JI (2007) Glutamate transporters: confining runaway excitation by shaping synaptic transmission. Nat Rev Neurosci 8:935–947

    CAS  PubMed  Google Scholar 

  • Urbina A, Jones K (2004) Crystal methamphetamine, its analogues, and HIV infection: medical and psychiatric aspects of a new epidemic. Clin Infect Dis 38:890–894

    PubMed  Google Scholar 

  • Varatharajan L, Thomas SA (2009) The transport of anti-HIV drugs across blood–CNS interfaces: summary of current knowledge and recommendations for further research. Antiviral Res 82:A99–A109

    CAS  PubMed  Google Scholar 

  • Vitkovic L, Bockaert J, Jacque C (2000) “Inflammatory”cytokines: neuromodulators in normal brain? J Neurochem 74:457–471

    CAS  PubMed  Google Scholar 

  • Wichers MC, Maes M (2004) The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression. J Psychiatry Neurosci 29:11–17

    PubMed  Google Scholar 

  • Wilson DR, Warise L (2008) Cytokines and their role in depression. Perspect Psychiatr Care 44:285–289

    PubMed  Google Scholar 

  • Wojtera M, Sikorska B, Sobow T, Liberski PP (2005) Microglial cells in neurodegenerative disorders. Folia Neuropathol 43:311–321

    CAS  PubMed  Google Scholar 

  • Xia Z, DePierre JW, Nassberger L (1996) Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology 34:27–37

    CAS  PubMed  Google Scholar 

  • Yadav A, Collman RG (2009) CNS inflammation and macrophage/microglial biology associated with HIV-1 infection. J Neuroimmune Pharmacol 4:430–447

    PubMed  Google Scholar 

  • Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280:5892–5901

    CAS  PubMed  Google Scholar 

  • Zhang L, Looney D, Taub D, Chang SL, Way D, Witte MH, Graves MC, Fiala M (1998) Cocaine opens the blood–brain barrier to HIV-1 invasion. J Neurovirol 4:619–626

    CAS  PubMed  Google Scholar 

  • Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC (2004) Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia. J Clin Psychiatry 65:940–947

    CAS  PubMed  Google Scholar 

  • Zheng J, Gendelman HE (1997) The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes. Curr Opin Neurol 10:319–325

    CAS  PubMed  Google Scholar 

  • Zink MC, Uhrlaub J, DeWitt J, Voelker T, Bullock B, Mankowski J, Tarwater P, Clements J, Barber S (2005) Neuroprotective and anti-human immunodeficiency virus activity of minocycline. JAMA 293:2003–2011

    CAS  PubMed  Google Scholar 

Download references

Conflict of interest

There are no conflicts of interest for any of the authors.

Author information

Authors and Affiliations

  1. Division of Mental Health and Addiction Medicine, Institute of Population Health Sciences, 35 Keyan Road, Zhunan, Miaoli County, 35053, Taiwan, Republic of China

    Feng-Shiun Shie, Yun-Hsiang Chen, Chia-Hsiang Chen & Ing-Kang Ho

Authors
  1. Feng-Shiun Shie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yun-Hsiang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chia-Hsiang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ing-Kang Ho
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ing-Kang Ho.

Additional information

FS Shie and YH Chen are the first authors with equal contribution.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shie, FS., Chen, YH., Chen, CH. et al. Neuroimmune Pharmacology of Neurodegenerative and Mental Diseases. J Neuroimmune Pharmacol 6, 28–40 (2011). https://doi.org/10.1007/s11481-010-9241-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11481-010-9241-8

Keywords

Search

Navigation